Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation. (2019). Mediterranean Journal of Hematology and Infectious Diseases, 11(1), e2019057. https://doi.org/10.4084/mjhid.2019.057